Tempest Therapeutics, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2016 | -76.0% | -76.0% | -67.1% |
| FY2017 | 64.7% | 65.0% | -426.9% |
| FY2018 | -38.3% | -38.1% | -32.3% |
| FY2019 | 88.5% | 88.8% | -59.4% |
| FY2020 | 27.9% | 27.9% | -84.0% |
| FY2021 | -78.4% | -55.3% | -38.6% |
| FY2022 | -197.2% | -125.4% | -77.5% |
| FY2023 | -110.2% | -89.3% | -57.1% |
| FY2024 | -218.8% | -218.8% | -100.9% |
| FY2025 | -393.9% | -393.9% | -155.1% |